ArticleMedical oncology (Northwood, London, England)2025

BH3 mimetic and dual PI3K/mTOR inhibitor attenuates gemcitabine resistance in triple-negative breast cancer.

Gizem Selimoglu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.